Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-16T15:58:34.127Z Has data issue: false hasContentIssue false
  • English
  • Français

Maintenance Pharmacotherapy for Recurrent Major Depressive Disorder in Primary Care: A 5-year Follow-up Study

Published online by Cambridge University Press:  27 January 2017

K. Riihimäki ,
M. Vuorilehto  and
E. Isometsä
K. Riihimäki
Affiliation:
Mental Health Unit, National Institute for Health and Welfare, Helsinki, Finland Health Care and Social Services, City of Järvenpää, Järvenpää, Finland
M. Vuorilehto
Affiliation:
Mental Health Unit, National Institute for Health and Welfare, Helsinki, Finland Department of Psychiatry, University of Helsinki, Helsinki University Hospital, Helsinki, Finland
E. Isometsä*
Affiliation:
Mental Health Unit, National Institute for Health and Welfare, Helsinki, Finland Department of Psychiatry, University of Helsinki, Helsinki University Hospital, Helsinki, Finland
*
⁎Corresponding author. Department of Psychiatry, Faculty of Medicine, University of Helsinki, P.O. Box 22, 00014 Helsinki, Finland. Tel.: +358 9 471 63728; fax: +358 9 471 63735. E-mail address:erkki.isometsa@hus.fi (E. Isometsä).
Get access

Abstract

Background

Most practice guidelines recommend maintenance antidepressant treatment for recurrent major depressive disorder. However, the degree to which such guidance is actually followed in primary health care has remained obscure. We investigated the provision of maintenance antidepressant treatment within a representative primary care five-year cohort study.

Methods

In the Vantaa Primary Care Depression Study, a stratified random sample of 1119 adult patients was screened for depression using the Prime-MD. Depressive and comorbid psychiatric disorders were diagnosed using SCID-I/P and SCID-II interviews. Of the 137 patients with depressive disorders, 82% completed the prospective five-year follow-up. A graphic life chart enabling evaluation of the longitudinal course of episodes plus duration of pharmacotherapies was used. In accordance with national guidelines, an indication for maintenance treatment was defined to exist after three or more lifetime major depressive episodes (MDEs); maintenance treatment was to commence four months after onset of full remission.

Results

Of the cohort patients, 34% (46/137) had three or more lifetime MDEs, thus indicating the requirement for maintenance pharmacotherapy. Of these, half (54%, 25/46) received maintenance treatment, for only 29% (489/1670) of the months indicated.

Conclusions

In this cohort of depressed primary care patients, half of patients with indications for maintenance treatment actually received it, and only for a fraction of the time indicated. Antidepressant maintenance treatment for the prevention of recurrences is unlikely to be subject to large-scale actualization as recommended, which may significantly undermine the potential public health benefits of treatment.

Keywords

DepressionMaintenance pharmacotherapyPrimary care
Type
Original article
Information
European Psychiatry , Volume 41 , Issue 1 , March 2017 , pp. 111 - 114
Copyright
Copyright © European Psychiatric Association 2017

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Gilchrist, G.Gunn, J.Observational studies of depression in primary care: what do we know? BMC Fam Pract 2007;8:28.CrossRefGoogle ScholarPubMed
American Psychiatric Association (APA). Practice guideline for the treatment of patients with major depressive disorder; 2010 [psychiatryonline.org].Google Scholar
Nice, , editor. Depression: the NICE guideline on the treatment and management of depression in adults (updated edition). London: National Institute for Health and Clinical Excellence; 2010.Google Scholar
The Finnish Medical Society Duodecim, Finnish Psychiatric Association Current care guideline (Käypä hoito -suositus): Depressio. Suomalaisen Lääkäriseuran Duodecimin ja Suomen Psykiatriyhdistys ry:n asettama työryhmä; 2014.Google Scholar
Kennedy, S.H.Lam, R.W.Parikh, S.V.Patten, S.B.Ravindran, A.V., Canadian network for mood and anxiety treatments (CANMAT). Clinical guidelines for the management of major depressive disorder in adults. J Affect Disord 2009;117:1–64.CrossRefGoogle ScholarPubMed
Sihvo, S.Isometsä, E.Kiviruusu, O.Hämäläinen, J.Suvisaari, J.Perälä, J., et al.Antidepressant utilisation patterns and determinants of short-term and non-psychiatric use in the Finnish general adult population. J Affect Disord 2008;110:94–105.CrossRefGoogle ScholarPubMed
Coupland, C.Hill, T.Morriss, R.Arthur, A.Moore, M.Hippisley-Cox, J.Antidepressant use and risk of suicide and attempted suicide or self harm in people aged 20 to 64: cohort study using a primary care database. BMJ 2015;350:517.CrossRefGoogle ScholarPubMed
Holma, I.Holma, K.Melartin, T.Isometsa, E.Maintenance pharmacotherapy for recurrent major depressive disorder: 5-year follow-up study. Br J Psychiatry 2008;193:163–164.CrossRefGoogle ScholarPubMed
Vuorilehto, M.Melartin, T.Isometsa, E.Depressive disorders in primary care: recurrent, chronic, and co-morbid. Psychol Med 2005;35:673–682.CrossRefGoogle ScholarPubMed
Riihimaki, K.A.Vuorilehto, M.S.Melartin, T.K.Isometsa, E.T.Five-year outcome of major depressive disorder in primary health care. Psychol Med 2011;16:1–11.Google Scholar
First, M.B.Spitzer, R.L.Gibbon, M.Williams, J.B.W., editors. Structured clinical interview for DSM-IV-TR axis I disorders, research version, patient edition with psychotic screen. New York: New York State Psychiatric Institute; 2002.Google Scholar
First, M.B.Gibbon, M.Spitzer, R.L.Williams, J.B.W.Benjamin, L.S., editors. Structured clinical interview for DSM-IV axis II personality disorders, (SCID-II). Washington, D.C: American Psychiatric Press, Inc; 1997.Google Scholar
Vuorilehto, M.Riihimäki, K.Isometsä, E.Pharmacological and psychosocial treatment of depression in primary care: low intensity and poor adherence and continuity. J Affect Disord 2016;202:145–152.CrossRefGoogle ScholarPubMed
Piek, E.Kollen, B.J.van der Meer, K.Penninx, B.W.Nolen, W.A.Maintenance use of antidepressants in Dutch general practice: non-guideline concordant. PLoS One 2014;23:e97463.CrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.